CEMI   $0.453  -0.22% Market Closed

Chembio Diagnostics Inc
Last Events:

2023-04-28 Signal in Stochastic changed from bullish weakening to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

2023-04-28 Signal in MACD changed from bearish weakening to bullish weakening. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

2023-04-28 Signal in RSI changed from bearish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

2023-04-28 Signal in EMA100 changed from bearish reversal to bullish reversal. 2023-03-28 the price crossed up the moving average line and demonstrates a strong upside trend.

2023-04-28 Signal in EMA50 changed from bearish reversal to bullish reversal. 2023-03-28 the price crossed up the moving average line and demonstrates an upside trend.

2023-04-28 Signal in EMA20 changed from bearish reversal to bullish reversal. 2023-03-28 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

2023-04-28 Trend Power changed from medium strength to almost flat.

2023-03-30 Trend pattern changed from восходящий клин to канал.


Current temperature: 0.38
ST: 0, Cor:

50-50 Year Forecast
Low with 51% probability: 0.39
Target: 8.00
High with 47% probability: 2.07
Analyst Recommendations:
Number of estimates 1
Target Price Mean 8.00
Mean unverified/preliminary 8.00 / 8.00
Target Price Low / High 8.00 / 8.00
Median / STD DEV 8.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell -
rsi Sell Sell -
macd - - -
stoch - - -
ma20 Sell Sell -
ma50 - - -
ma100 Sell Sell -
Candlestick PatternMarch 2, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US1635722093
ceo Mr. Richard L. Eberly
Website https://chembio.com
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID 19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, NEXT GENERATION DPP, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York. As of April 27, 2023, Chembio Diagnostics, Inc. operates as a subsidiary of Biosynex SA.